The Hook: Could 30 mg Do What People Usually Take 10-20 Times More For?
Ashwagandha supplements are usually sold in the hundreds of milligrams. A new randomized trial in Phytotherapy Research (Prajapati et al.) tested a dose of just 30 mg per day. According to the abstract, that was enough to significantly improve VO2max compared with placebo over eight weeks.
Before you reorganize your supplement shelf, here is what the study reports, what it leaves out, and who it applies to.
What Was Tested: Not Your Average Ashwagandha
The product was not generic root powder. The researchers used a low-dose ashwagandha (LDA), branded in the paper as Ashwa.30. The abstract describes it as a "bioactive-optimized root-only extract" standardized to:
- Withanolides: more than 15% w/w
- An "ATP-active fraction": more than 15% w/w
This matters. The 30 mg result applies to this specific standardized extract, not to any bottle labeled "ashwagandha." A 30 mg dose of a poorly standardized product is a different thing entirely, and the study can't speak to it.
The Study Design
The trial was an eight-week, randomized, double-blind, placebo-controlled study in healthy adults. Participants took either 30 mg/day of LDA or a placebo.
- Primary endpoint: VO2max, estimated indirectly with the Modified Bruce Protocol Treadmill Test (MBPTT).
- Secondary endpoints: lactic acid, creatine phosphokinase (CPK), Rating of Perceived Exertion (RPE), fatigue scores on a visual analog scale (VAS), and safety biomarkers.
The VO2max figure was estimated from a treadmill protocol, not measured directly with gas-exchange analysis. That is a common practical approach, but it is less precise than lab-grade measurement.
The Headline Results (As the Abstract States Them)
VO2max: LDA "significantly improved VO2max and maximal heart rate compared to the placebo." The abstract gives no numbers for the size of the improvement, so I won't invent any. You would need the full paper for effect sizes, confidence intervals, and sample size.
Fatigue: "Borg RPE and fatigue scores improved in the LDA group." The authors conclude the supplement "delayed fatigue onset."
Lactic acid: The treatment group showed lower lactic acid levels at exercise, which the authors interpret as "prolonged aerobic metabolism."
CPK: Levels were "significantly reduced," which the authors suggest points to "mitigation of muscle energy stress." CPK is a marker often associated with muscle strain, but the abstract doesn't say whether this translated into better recovery or fewer injuries. Treat it as a biomarker finding, not a proven recovery benefit.
Safety: What the Abstract Reports
LDA was "well tolerated, with no treatment-related adverse events." Hematological, hepatic, renal, metabolic, and vital sign parameters stayed within normal clinical ranges. That is reassuring for healthy adults over eight weeks, but it is a short window in a healthy population.
Practical Takeaways
Dose: 30 mg/day of the specific standardized extract, which is what the trial used. The abstract doesn't test other doses, so it can't tell you whether 30 mg beats, matches, or falls short of 300-600 mg. Higher doses are common in other ashwagandha research, but this study did not compare them head-to-head.
Duration: Eight weeks. Don't expect a one-workout effect.
Timing: The abstract doesn't say when during the day participants took it. Check the full text rather than guessing.
Who it's for: The evidence applies to healthy adults interested in cardiorespiratory fitness and lower exercise-related fatigue. The authors describe it as a potential "safe and effective low-dose aid for endurance enhancement."
- Anyone with a medical condition or on medication. The trial enrolled healthy adults, so the results don't cover you. Talk to a clinician first, especially if you are pregnant, have thyroid, liver, or autoimmune issues, or are on prescription drugs. This is general caution, not something the abstract tests.
- Anyone who wants a proven, large performance jump. Without effect sizes in the abstract, "significant" tells you the result was statistically notable, not that it was dramatic.
- Anyone buying a different ashwagandha product. The results are tied to this standardized extract.
Industry Links and Caveats
The abstract does not state funding sources or conflicts of interest. The extract is a branded, proprietary product (Ashwa.30), and supplement trials of branded ingredients are often connected to the manufacturer. That is a reason to check the full paper's disclosures, not evidence of bias. Other limits to keep in mind:
- It is a single trial, and the abstract doesn't give the sample size.
- VO2max was indirectly estimated.
- Eight weeks in healthy adults says little about long-term use or elite athletes.
- No head-to-head comparison with higher ashwagandha doses was reported.
Bottom Line
A 30 mg dose of a standardized, root-only ashwagandha extract improved estimated VO2max and fatigue measures against placebo over eight weeks, with no treatment-related adverse events reported. That is an interesting result for anyone who thinks more milligrams always means more benefit. It still needs replication, independent confirmation, and a look at the full paper's numbers and disclosures before anyone calls it a game changer.
Source: Prajapati et al., "Efficacy and Safety of Low-Dose Ashwagandha Supplementation on Exercise Endurance: A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial," Phytotherapy Research. DOI: 10.1002/ptr.70178. PubMed: https://pubmed.ncbi.nlm.nih.gov/41846233/